WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Short Interest Down 32.6% in August

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) saw a large decrease in short interest during the month of August. As of August 14th, there was short interest totaling 31,255 shares, a decrease of 32.6% from the July 30th total of 46,353 shares. Based on an average trading volume of 61,760 shares, the days-to-cover ratio is presently 0.5 days. Currently, 0.0% of the company’s shares are short sold.

WuXi Biologics (Cayman) Stock Performance

WXXWY opened at $12.67 on Thursday. The stock’s 50 day simple moving average is $10.61 and its 200-day simple moving average is $9.44. WuXi Biologics has a 1 year low of $7.30 and a 1 year high of $13.43.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded shares of WuXi Biologics (Cayman) to a “hold” rating in a research note on Friday, August 28th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company has an average rating of “Hold”.

About WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.